Search - tctmd.com

Displaying 261 - 280 of 310

Sort: Relevancy | Date

News Daily News

Sapien 3 Approved for Use in Intermediate-Risk Patients in Europe

Michael O'Riordan

September 20, 2016

News Conference News ESC 2016

New ESC A-fib Guidelines Call for Integrated Care for All Patients

Todd Neale

August 27, 2016

News Daily News

TAVR as an Option for Intermediate-Risk Patients: Physicians Respond

Yael L. Maxwell

August 24, 2016

News Daily News

FDA Approves Sapien XT and Sapien 3 for Intermediate-Risk Patients

Yael L. Maxwell

August 18, 2016

News Daily News

Decline Seen in Readmissions After PCI in the Medicare Population

Todd Neale

July 21, 2016

News Conference News EuroPCR 2016

From Italy to Bangladesh: STEMI Networks Matter

Caitlin E. Cox

May 18, 2016

News Features

Where Theory Meets Practice: Getting to the Heart of the Heart Team

Yael L. Maxwell

March 30, 2016

News Daily News

Controversial LIGHT Trial Now Published but Fails to Illuminate CV Risks of Contrave

Michael O'Riordan

March 08, 2016

News Conference News TCT 2015

Boston Scientific Co-founder John Abele Recognized by TCT Career Achievement Award

October 12, 2015

News Industry News

Corindus Vascular Robotics and Unfors RaySafe Partner to Protect Against Physician and Staff Radiation Exposure in the Cath Lab

August 18, 2015

News Features

Opportunities Exist for Hospitals, Interventionalists to Stave Off Unnecessary Readmissions

July 28, 2015

News Industry News

Micell Technologies Announces First Patient Enrolled in Registration Trial of MiStent SES in China

July 22, 2015

News Daily News

Survival Benefit of CoreValve in High-Risk Patients Persists at 2 Years

July 07, 2015

News Daily News

El Beneficio sobre la Supervivencia de CoreValve en Pacientes de Alto Riesgo se Mantiene a los 2 Años

July 07, 2015

News Daily News

CoreValve在高风险患者中的生存益处到2年时依然持续存在

July 07, 2015

News Industry News

New Cost Effectiveness Model Underlines Scope of Polypill Strategy to Prevent Recurring Cardiovascular Events and for More Efficient Use of Health Budgets

June 19, 2015

News Industry News

Neuravi Announces €19M ($21M) in Financing to Advance Innovative Minimally Invasive Stroke Therapy

June 17, 2015

News Daily News

即便经验更丰富，经心尖TAVR带给患者的生活质量也并不好于外科手术

Caitlin E. Cox

June 15, 2015

News Daily News

Incluso con Más Experiencia la TAVR Transapical No ofrece una Mejor Calidad de Vida que la Cirugía

Caitlin E. Cox

June 15, 2015

News Daily News

Even With More Experience, Transapical TAVR Offers No Better QoL Than Surgery

Caitlin E. Cox

June 15, 2015

Advertisement

Sapien 3 Approved for Use in Intermediate-Risk Patients in Europe

New ESC A-fib Guidelines Call for Integrated Care for All Patients

TAVR as an Option for Intermediate-Risk Patients: Physicians Respond

FDA Approves Sapien XT and Sapien 3 for Intermediate-Risk Patients

Decline Seen in Readmissions After PCI in the Medicare Population

From Italy to Bangladesh: STEMI Networks Matter

Where Theory Meets Practice: Getting to the Heart of the Heart Team

Controversial LIGHT Trial Now Published but Fails to Illuminate CV Risks of Contrave

Boston Scientific Co-founder John Abele Recognized by TCT Career Achievement Award

Corindus Vascular Robotics and Unfors RaySafe Partner to Protect Against Physician and Staff Radiation Exposure in the Cath Lab

Opportunities Exist for Hospitals, Interventionalists to Stave Off Unnecessary Readmissions

Micell Technologies Announces First Patient Enrolled in Registration Trial of MiStent SES in China

Survival Benefit of CoreValve in High-Risk Patients Persists at 2 Years

El Beneficio sobre la Supervivencia de CoreValve en Pacientes de Alto Riesgo se Mantiene a los 2 Años

CoreValve在高风险患者中的生存益处到2年时依然持续存在

New Cost Effectiveness Model Underlines Scope of Polypill Strategy to Prevent Recurring Cardiovascular Events and for More Efficient Use of Health Budgets

Neuravi Announces €19M ($21M) in Financing to Advance Innovative Minimally Invasive Stroke Therapy

即便经验更丰富，经心尖TAVR带给患者的生活质量也并不好于外科手术

Incluso con Más Experiencia la TAVR Transapical No ofrece una Mejor Calidad de Vida que la Cirugía

Even With More Experience, Transapical TAVR Offers No Better QoL Than Surgery

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content